الأقسام والتخصصات

تضم Mayo Clinic أكبر العيادات وأكثرها خبرة في الولايات المتحدة الأمريكية، وتوجد فروعها في ولاية أريزونا وفلوريدا ومينيسوتا. ويتعاون كادرها الماهر المكون من عدة تخصصات لضمان تقديم علاج ناجح ورعاية عالية الجودة.

الأقسام ذات الخبرة المرتبطة بهذا المجال

الأطباء الذين يؤدون هذا الإجراء

edit search filters
Close

Narrow your search

  1. Find a doctor whose last name begins with the letter A
  2. Find a doctor whose last name begins with the letter B
  3. Find a doctor whose last name begins with the letter C
  4. Find a doctor whose last name begins with the letter D
  5. There are no doctors whose last name begins with the letter E
  6. Find a doctor whose last name begins with the letter F
  7. Find a doctor whose last name begins with the letter G
  8. Find a doctor whose last name begins with the letter H
  9. Find a doctor whose last name begins with the letter I
  10. Find a doctor whose last name begins with the letter J
  11. Find a doctor whose last name begins with the letter K
  12. active Find a doctor whose last name begins with the letter L
  13. Find a doctor whose last name begins with the letter M
  14. Find a doctor whose last name begins with the letter N
  15. There are no doctors whose last name begins with the letter O
  16. Find a doctor whose last name begins with the letter P
  17. There are no doctors whose last name begins with the letter Q
  18. Find a doctor whose last name begins with the letter R
  19. Find a doctor whose last name begins with the letter S
  20. Find a doctor whose last name begins with the letter T
  21. There are no doctors whose last name begins with the letter U
  22. Find a doctor whose last name begins with the letter V
  23. There are no doctors whose last name begins with the letter W
  24. There are no doctors whose last name begins with the letter X
  25. There are no doctors whose last name begins with the letter Y
  26. There are no doctors whose last name begins with the letter Z
Reset all filters

Displaying 1-3 out of 3 doctors available

Last Name Initial: L

  1. Martha Q. Lacy, M.D.

    Martha Q. Lacy, M.D.

    1. Hematologist
    1. Rochester, MN
    Areas of focus:

    Autologous stem cell transplant, Allogeneic stem cell transplant, Bone marrow transplant, Multiple myeloma, Amyloidosis..., Waldenstrom macroglobulinemia, High blood protein

  2. Jose F. Leis, M.D., Ph.D.

    Jose F. Leis, M.D., Ph.D.

    1. Internist
    2. Hematologist
    1. Phoenix, AZ
    Areas of focus:

    Autologous stem cell transplant, Allogeneic stem cell transplant, Chronic lymphocytic leukemia

  3. Mark R. Litzow, M.D.

    Mark R. Litzow, M.D.

    1. Hematologist
    2. Palliative Care Specialist
    3. Oncologist
    1. Rochester, MN
    Areas of focus:

    Bone marrow transplant, Myeloproliferative disorders, Myelodysplastic syndromes, Chronic myelogenous leukemia, Acute le...ukemia

البحث

يدرس أطباء وعلماء Mayo Clinic بطريقة عملية طرق تحسين نتائج زراعة نخاع العظم. تتضمن مجالات البحث ما يلي:

  • توسيع استخدام زراعة نخاع العظم متماثل النمط الفرداني
  • البحث عن طرق جديدة لاستخدام زراعة نخاع العظم، ويشمل ذلك اعتلال الهيموغلوبين لدى الأطفال والأمراض الأيضية الموروثة
  • تحسين نوعية الحياة للناجين من زراعة نخاع العظم
  • منع داء الطعم حيال المضيف (GVHD) والتعامل معه
  • فهم داء الطعم حيال المضيف المزمن

تعرَّف أكثر على الأبحاث ضمن برنامج زراعة نخاع العظم.

تُجرَى الأبحاث على السرطان بالتعاون مع مركز Mayo Clinic للسرطان. يتلقَّى مركز Mayo Clinic للسرطان تمويلًا من المعهد الوطني للسرطان، ويُعرَف بأنه مركز شامل للسرطان — ويتميَّز بالتفوُّق العلمي، ويتبع نهجًا متعدِّد التخصُّصات يُركِّز على الوقاية من السرطان وتشخيصه وعلاجه.

المنشورات

اطَّلِعْ على قائمة المنشورات حول زراعة نخاع العظم التي أعَدَّها أطباء Mayo Clinic على منصة PubMed، وهي خدمة تابعة للمكتبة الوطنية للطب.

ملامح البحوث

زراعة نخاع العظم - الرعاية في Mayo Clinic (مايو كلينك)

24/10/2019
  1. AskMayoExpert. Hematopoietic stem cell transplant. Mayo Clinic; 2019.
  2. Hoffman R, et al. Overview of hematopoietic stem cell transplantation. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed July 8, 2016.
  3. Blood-forming stem cell transplants. National Cancer Institute. http://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet. Accessed July 8, 2016.
  4. Majhail NS, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 2012;18:348.
  5. Diseases treatable by transplants. National Marrow Donor Program. https://bethematch.org/transplant-basics/how-transplants-work/diseases-treatable-by-transplants/. Accessed Aug. 1, 2019.
  6. AskMayoExpert. Graft-versus-host disease. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  7. Blood and marrow stem cell transplantation. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Aug. 1, 2019.
  8. Barbara Woodward Lips Patient Education Center. Autologous stem cell transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  9. Blood and bone marrow transplant. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/blood-and-bone-marrow-transplant. Accessed Aug. 13, 2019.
  10. D'Souza A, et al. Current use and trends in hematopoietic cell transplantation in the United States. Biology of Blood and Marrow Transplantation. 2017; doi:10.1016/j.bbmt.2017.05.035.
  11. Jagasia MH, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015; doi:10.1016/j.bbmt.2014.12.001.
  12. Blood and marrow transplant (BMT): An introduction to allogeneic BMT. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Aug. 1, 2019.
  13. Majhail NS. Long term complications after hematopoietic cell transplantation. Hematology Oncology Stem Cell Therapy. 2017; doi:10.1016/j.hemonc.2017.05.009.
  14. Hashmi SK, et al. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group report. Biology of Blood and Marrow Transplantation. 2017; doi:10.1016/j.bbmt.2016.09.025.
  15. DeFilipp Z, et al. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: Screening and preventive practice recommendations from CIBMTR and EBMT. Biology of Blood and Marrow Transplantation. 2016; doi:10.1038/bmt.2016.203.
  16. Mills SD, et al. Bone-marrow transplant in an identical twin. JAMA. 1964; doi:10.1001/jama.1964.03060380005001.
  17. Rashidi A, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 2019; doi:10.1182/bloodadvances.2019000050.
  18. Ahmed S, et al. Lower graft-versus-host disease and relapse risk in post-transplant cyclophosphamide-based haploidentical versus matched sibling donor reduced-intensity conditioning transplant for Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2019.05.025.
  19. Jain T, et al. Choosing a reduced-intensity conditioning regimen for allogeneic stem cell transplantation, fludarabine/busulfan versus fludarabine melphalan: A systematic review and meta-analysis. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2018.11.016.
  20. Chen YB, et al. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 2019; doi:10.1182/bloodadvances.2018027599.
  21. Ballen KK, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: Comparison among alternative graft sources. Biology of Blood and Marrow Transplantation. 2014; doi:10.1016/j.bbmt.2014.07.021.
  22. Sweeney SK, et al. Tracking embryonic hematopoietic stem cells to the bone marrow: Nanoparticle options to evaluate transplantation efficiency. Stem Cell Research & Therapy. 2018; doi:10.1186/s13287-018-0944-8.
  23. Kumar A, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis: An updated systematic review and meta-analysis. Bone Marrow Transplantation. 2019; doi:10.1038/s41409-018-0393-0.
  24. Graff TM, et al. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015; doi: 10.1038/bmt.2015.46.
  25. Brown AY. Allscripts EPSi. Mayo Clinic. Sept. 16, 2019.
  26. Search for a FACT accredited organization. Foundation for the Accreditation of Cellular Therapy (FACT). http://accredited.factwebsite.org/. Accessed Aug. 13, 2019.
  27. Transplant center search results. Be The Match. https://bethematch.org/tcdirectory/search/advanced/#mayo/-/-/false/-.Accessed Aug. 13, 2019.
  28. Participating transplant centers. Center for International Blood and Marrow Transplant Research. https://www.cibmtr.org/About/WhoWeAre/Centers/Pages/index.aspx?country=us&state=Minnesota. Accessed Aug. 13, 2019.
  29. Locations. Children's Oncology Group. https://childrensoncologygroup.org/index.php/locations/. Accessed Aug. 13, 2019.
  30. Participating institutions. ECOG-ACRIN Cancer Research Group. https://ecog-acrin.org/participating-institutions. Accessed Aug. 13, 2019.
  31. PBMTC members. Pediatric Blood and Marrow Transplant Consortium. http://www.pbmtc.org/about/members/full. Accessed Aug. 13, 2019.
  32. Participating clinical centers. Primary Immune Deficiency Treatment Consortium. https://www.rarediseasesnetwork.org/cms/pidtc/Learn-More/Participating-Clinical-Centers. Accessed Aug. 13, 2019.